Trexquant Investment LP Immunocore Holdings PLC Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$42.85 - $69.5 $74,816 - $121,347	1,746 Added 6.52%	28,545 $1.95 Million
Q3 2023 Nov 13, 2023	BUY	$49.5 - $66.6 $929,016 - $1.25 Million	18,768 Added 233.69%	26,799 $1.39 Million
Q2 2023 Aug 11, 2023	SELL	$48.54 - $61.64 $1.42 Million - $1.8 Million	-29,213 Reduced 78.44%	8,031 $481,000
Q1 2023 May 15, 2023	BUY	$46.12 - $65.71 $968,151 - $1.38 Million	20,992 Added 129.17%	37,244 $1.84 Million
Q4 2022 Feb 13, 2023	BUY	$45.51 - $65.08 $739,628 - $1.06 Million	16,252 New	16,252 $927,000

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.